GDP-6-azidofucose disodium salt—an innovative tool for glycosylation research 944560-34-3

GDP-6-azido-Fucosedisodium salt is a key molecule in the field of sugar nucleotides and plays an important role in modern glycobiology and biomedicine research. As one of the core substrates of the glycosylation process in cells, it combines the biological function of fucose with the chemical operability of the azide group, providing a powerful platform for exploring the synthesis, modification and application of glycoconjugates. From basic mechanism research to innovative therapeutic design, this compound is becoming an indispensable ingredient in advancing the frontiers of glycoscience.

Chemical Information

Chemical name: GDP-6-azidofucose disodium salt

Common name: GDP-6-azido-Fucose disodium salt

Chemical formula: C16H22N8Na2O15P2

Molecular weight: 674.32 g/mol

CAS number: 944560-34-3

Category: Sugar Nucleotides

Structural features

The structure of GDP-6-azidofucose disodium salt combines the properties of nucleotides and modified sugars. Its unique features are:

l The GDP skeleton provides the basis for biological activity: As a guanosine diphosphate (GDP) derivative, this compound retains the high-energy phosphate bonds and enzyme recognition sites of natural sugar nucleotides, allowing it to be effectively utilized by fucosyltransferases and participate in the intracellular glycosylation pathway.

l The fucose unit confers biological functions: Fucose is a six-carbon deoxysaccharide that is widely present in glycoproteins and glycolipids and participates in key processes such as cell recognition, immune regulation, and signal transduction. The C6 position in its structure is specifically modified by an azide group (-N3), realizing the expansion of chemical functions.

l Azide modification enables click chemistry: The introduction of the azide group enables the compound to undergo efficient and specific covalent coupling with alkynyl-modified molecules through click chemical reactions such as copper-catalyzed azide-alkyne cycloaddition. This property provides flexibility for bioorthogonal labeling and engineering while maintaining the biocompatibility of fucose itself.

l Disodium salt form enhances solubility and stability: As a disodium salt, the compound exhibits good solubility and chemical stability in aqueous buffer systems, making it easy to operate and store in in vitro experiments and biological applications.

Main applications and advantages

Core tools for glycosylation mechanism research and enzymatic analysis

In glycobiology, fucosylation is an important step in post-translational modification of proteins and lipids and is closely related to cancer, inflammation and developmental diseases. GDP-6-azidofucose disodium salt can be used as a specific substrate for fucosyltransferase and can be used for in vitro enzyme activity measurement, kinetic studies and structural analysis to help reveal the regulatory mechanism of the glycosylation pathway. Its azide tag allows for fluorescent labeling or enrichment of modification products via click chemistry, enabling highly sensitive detection and thereby advancing the field of glycomics.

Application platform of chemical biology and glycoengineering

Utilizing the reactivity of the azide group, the compound can serve as a "chemical handle" to precisely introduce fucose modules into biomolecules such as antibodies, cell surface glycoconjugates or nanoparticles for the construction of engineered sugar structures. This strategy has broad potential in targeted drug delivery, cell imaging, and immune modulation, for example by modifying antibodies to enhance their affinity for receptors or developing diagnostic probes based on sugar recognition. Compared with traditional methods, click chemical coupling has high efficiency and low background interference, providing new ideas for synthetic biology and biomanufacturing.

Precursor molecules for drug development and therapeutic innovation

In the field of biomedicine, abnormal fucosylation is associated with various pathological conditions, such as tumor metastasis and autoimmune diseases. GDP-6-azidofucose disodium salt can be used as a precursor to synthesize glycosylation inhibitors or mimetics to explore therapeutic pathways by interfering with abnormal glycosylation processes. In addition, its azide functionalization properties support the development of conjugated drugs, such as combining fucose units with toxins or imaging agents to achieve specific identification and intervention of diseased tissues, laying the foundation for personalized medicine and precision therapy.

Conclusion

GDP-6-azidofucose disodium salt is not only a chemical entity, but also a bridge connecting basic research in glycoscience and clinical translation. From deciphering the molecular details of cellular communication to designing next-generation glycosylation therapies, its unique structure and application potential are constantly pushing the boundaries of life sciences. With the integration and evolution of glycobiology and click chemistry technologies, this compound is expected to play a more profound role in the development of diagnostic tools, vaccine design and treatment of rare diseases, injecting innovative vitality into human health.

The above information is provided by the editor of KASONS and is for scientific research only.